Dysregulation of bacterial proteolytic machinery by a new class of antibiotics

Article Abstract:

A demonstration that a new class of antibiotics, acyldepsipeptides, has antibacterial activity against Gram-positive bacteria in vitro and in several rodent models of bacterial infection is presented. It is shown that the acyldepsipeptides are active against isolates that are resistant to antibiotics in clinical application, implying a new target, which is identified as ClpP, the core unit of a major bacterial protease complex.

Care and treatment, Bacterial infections

---

Antibacterial discovery and development-the failure of success?

Article Abstract:

The path taken over six decades of antibacterial research and development is traced.The industry trends that emerged at different times to combat new challenges and relevant lessons from antibacterial compound discovery and the relevant lessons for present-day antibacterial compound discovery, current approaches to combat resistance, and problems with regulatory oversight and commercial development issues are discussed.

Forecasts, trends, outlooks, Forecasts and trends, Market trend/market analysis, Pharmaceutical research

---

Drugs for bad bugs: Confronting the challenges of antibacterial discovery

Article Abstract:

A study was conducted with the objective of finding a novel antibacterial compound that had either Gram-positive or broad-spectrum activity. The findings reveal that synthesizing novel chemical structures that interact with and block established targets in new ways is a robust strategy.

Drug therapy, Gram-positive bacteria

Similar abstracts:

• Abstracts: Validation of fetal telemedicine as a new obstetric imaging technique. First-trimester or second-trimester screening, or both, for Down's syndrome
• Abstracts: The integration of clinical research into dental therapeutics
• Abstracts: Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
• Abstracts: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
• Abstracts: Opportunities in critical care oncology. Hearing aid

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.